Quest Diagnostics
An Interview with Jon R. Cohen, MD, senior VP and chief medical officer, Quest Diagnostics
Read More
Search Results for: lung cancer
Fujirebio Diagnostics’ CYFRA 21-1 EIA Assay Earns 510(k) Clearance
This is the first biomarker assay kit to be cleared by the FDA for use in the management of patients with lung cancer.
Read MoreAACC Hosts Prostate Cancer Screening Webinar
Some argue that there is not enough evidence to suggest PSA’s use as a screening tool improves patient survival, but others believe the test has been instrumental in reducing mortality from prostate cancer in the US.
Read MoreNews Story #15330
Luminex Wins Medical Design Excellence Award Luminex Corp, Austin, Tex, has won a 2011 Medical Design Excellence Award in the category of In Vitro Diagnostics for its innovative MAGPIX system. Introduced in 2010, MAGPIX is a co
Read MoreNews Story #15316
Amgen Cancer Drug Fails in Phase 3 Study Thousand Oaks, Calif — Amgen, Cambridge, Mass-based Millennium: The Takeda Oncology Company, and Takeda Pharmaceutical Co, Osaka, Japan, announced the top-line results from the pivotal
Read More